[Use of LMW heparin: information for prescribers. Update: 10 April 2002].
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000075202:Contraindications; D003404:Creatinine / Q000097:blood; D004347:Drug Interactions; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010976:Platelet Count; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications; D013921:Thrombocytopenia / Q000139:chemically induced; D020246:Venous Thrombosis / Q000517:prevention & control; D014812:Vitamin K / Q000494:pharmacology
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D003404:Creatinine